Rare diseases
Investigational molecules
Locations
Oberburgau 3, Oberburgau, 4866, Austria
Ever Neuro Pharma GmbH is involved in clinical research focused on Cerebral Autosomal Dominant Arteriopathy with subcortical Infarcts and Leukoencephalopathy (CADASIL), a rare inherited disorder affecting the brain’s small blood vessels and associated with progressive white matter disease, recurrent stroke, and cognitive decline.
The sponsor’s research interest centers on neurological conditions linked to cerebrovascular pathology and long-term impairment of brain function.
Ever Neuro Pharma GmbH runs clinical trials in conditions such as Arterial disorder, Leukoencephalopathy, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
